BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25625310)

  • 1. Prevalence of chromosomal rearrangements involving non-ETS genes in prostate cancer.
    Kluth M; Galal R; Krohn A; Weischenfeldt J; Tsourlakis C; Paustian L; Ahrary R; Ahmed M; Scherzai S; Meyer A; Sirma H; Korbel J; Sauter G; Schlomm T; Simon R; Minner S
    Int J Oncol; 2015 Apr; 46(4):1637-42. PubMed ID: 25625310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer.
    Mehra R; Tomlins SA; Yu J; Cao X; Wang L; Menon A; Rubin MA; Pienta KJ; Shah RB; Chinnaiyan AM
    Cancer Res; 2008 May; 68(10):3584-90. PubMed ID: 18483239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer.
    Tomlins SA; Laxman B; Dhanasekaran SM; Helgeson BE; Cao X; Morris DS; Menon A; Jing X; Cao Q; Han B; Yu J; Wang L; Montie JE; Rubin MA; Pienta KJ; Roulston D; Shah RB; Varambally S; Mehra R; Chinnaiyan AM
    Nature; 2007 Aug; 448(7153):595-9. PubMed ID: 17671502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer.
    Han B; Mehra R; Dhanasekaran SM; Yu J; Menon A; Lonigro RJ; Wang X; Gong Y; Wang L; Shankar S; Laxman B; Shah RB; Varambally S; Palanisamy N; Tomlins SA; Kumar-Sinha C; Chinnaiyan AM
    Cancer Res; 2008 Sep; 68(18):7629-37. PubMed ID: 18794152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancers.
    Rajput AB; Miller MA; De Luca A; Boyd N; Leung S; Hurtado-Coll A; Fazli L; Jones EC; Palmer JB; Gleave ME; Cox ME; Huntsman DG
    J Clin Pathol; 2007 Nov; 60(11):1238-43. PubMed ID: 17259299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of ETS gene aberrations in select histologic variants of prostate carcinoma.
    Han B; Mehra R; Suleman K; Tomlins SA; Wang L; Singhal N; Linetzky KA; Palanisamy N; Zhou M; Chinnaiyan AM; Shah RB
    Mod Pathol; 2009 Sep; 22(9):1176-85. PubMed ID: 19465903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FLI1 is a novel ETS transcription factor involved in gene fusions in prostate cancer.
    Paulo P; Barros-Silva JD; Ribeiro FR; Ramalho-Carvalho J; Jerónimo C; Henrique R; Lind GE; Skotheim RI; Lothe RA; Teixeira MR
    Genes Chromosomes Cancer; 2012 Mar; 51(3):240-9. PubMed ID: 22081504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ETS fusion genes in prostate cancer.
    Gasi Tandefelt D; Boormans J; Hermans K; Trapman J
    Endocr Relat Cancer; 2014 Jun; 21(3):R143-52. PubMed ID: 24659477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohort.
    Esgueva R; Perner S; J LaFargue C; Scheble V; Stephan C; Lein M; Fritzsche FR; Dietel M; Kristiansen G; Rubin MA
    Mod Pathol; 2010 Apr; 23(4):539-46. PubMed ID: 20118910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of TMPRSS2-ETS fusions by a multiprobe fluorescence in situ hybridization assay for the early diagnosis of prostate cancer: a pilot study.
    Sun QP; Li LY; Chen Z; Pang J; Yang WJ; Zhou XF; Qiu JG; Su ZL; He D; Gao X
    J Mol Diagn; 2010 Sep; 12(5):718-24. PubMed ID: 20616363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Frequency and transcript variant analysis of gene fusions between TMPRSS2 and ETS transcription factor genes in prostate cancer].
    Dai MJ; Chen LL; Zheng YB; Chen W; Tao ZH; Weng ZL; Wu XL; Li CD; Chen ZG; Chen XD; Shi SB
    Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(10):669-73. PubMed ID: 18642766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer.
    Rickman DS; Pflueger D; Moss B; VanDoren VE; Chen CX; de la Taille A; Kuefer R; Tewari AK; Setlur SR; Demichelis F; Rubin MA
    Cancer Res; 2009 Apr; 69(7):2734-8. PubMed ID: 19293179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetic analyses of the TMPRSS2-ERG and TMPRSS2-ETV1 gene fusions in 50 cases of prostate cancer.
    Winnes M; Lissbrant E; Damber JE; Stenman G
    Oncol Rep; 2007 May; 17(5):1033-6. PubMed ID: 17390040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide linkage analysis of TMPRSS2-ERG fusion in familial prostate cancer.
    Hofer MD; Kuefer R; Maier C; Herkommer K; Perner S; Demichelis F; Paiss T; Vogel W; Rubin MA; Hoegel J
    Cancer Res; 2009 Jan; 69(2):640-6. PubMed ID: 19147579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer.
    Mehra R; Tomlins SA; Shen R; Nadeem O; Wang L; Wei JT; Pienta KJ; Ghosh D; Rubin MA; Chinnaiyan AM; Shah RB
    Mod Pathol; 2007 May; 20(5):538-44. PubMed ID: 17334343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ETS gene fusions in prostate cancer.
    Clark JP; Cooper CS
    Nat Rev Urol; 2009 Aug; 6(8):429-39. PubMed ID: 19657377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing.
    Pflueger D; Terry S; Sboner A; Habegger L; Esgueva R; Lin PC; Svensson MA; Kitabayashi N; Moss BJ; MacDonald TY; Cao X; Barrette T; Tewari AK; Chee MS; Chinnaiyan AM; Rickman DS; Demichelis F; Gerstein MB; Rubin MA
    Genome Res; 2011 Jan; 21(1):56-67. PubMed ID: 21036922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen regulation of ETS gene fusion transcripts in prostate cancer.
    Gasi D; Trapman J
    Methods Mol Biol; 2011; 776():335-48. PubMed ID: 21796535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of the TMPRSS2-ETS fusion gene in prostate carcinomas: retrospective analysis of 55 formalin-fixed and paraffin-embedded samples with clinical data.
    Rouzier C; Haudebourg J; Carpentier X; Valério L; Amiel J; Michiels JF; Pedeutour F
    Cancer Genet Cytogenet; 2008 May; 183(1):21-7. PubMed ID: 18474293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic, Environmental, and Nuclear Factors Governing Genomic Rearrangements.
    Ramanand SG; Mani RS
    Adv Exp Med Biol; 2019; 1210():57-66. PubMed ID: 31900904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.